Evidence map›Paper›PMID 31965554›Full record

ArticleNeurochemical research2020

Involvement of Orexinergic System Within the Nucleus Accumbens in Pain Modulatory Role of the Lateral Hypothalamus in Orofacial Pain Model.

Amir Haghparast, Tina Matini, Laleh Rezaee, Mohammad Rahban, Azita Tehranchi, Abbas Haghparast

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amir HaghparastSchool of Dentistry, International Branch of Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tina MatiniSchool of Dentistry, International Branch of Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Laleh RezaeeSchool of Medicine, Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, P O Box 19615-1178, Tehran, Iran.
Mohammad RahbanSchool of Medicine, Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, P O Box 19615-1178, Tehran, Iran.
Azita TehranchiSchool of Dentistry, Dental Deformities Research Center, Dental Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Azitatehranchi@yahoo.com.
Abbas HaghparastSchool of Medicine, Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, P O Box 19615-1178, Tehran, Iran. Haghparast@yahoo.com.ORCID http://orcid.org/0000-0003-1084-180X
Shahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lateral hypothalamus (LH) contains a large population of orexinergic neurons. Many studies have investigated the function of these neurons and it is clear that they are involved in pain modulation. The nucleus accumbens (NAc) receives many orexinergic projections, and accumbal neurons express both receptors of orexin (OX1R and OX2R). In this study, we investigated the role of accumbal orexinergic receptors in the LH-induced antinociception during formalin-induced orofacial pain. Male adult Wistar rats weighing 230-250 g were used in this study. Cannulae were unilaterally implanted in their skull for microinjections. SB334867 (OX1 receptor antagonist) or TCS OX2 29 (OX2 receptor antagonist) at the doses of 3, 10 and 30 nM were injected into the NAc with/without intra-LH microinjection of carbachol (250 nM/rat). Carbachol was used for chemical stimulation of orexinergic neurons in the LH. Our results showed that intra-LH carbachol following injection of formalin into animals' upper lip reduced nociception in both phases of formalin test. SB334867 and TCS OX2 29 were able to reduce LH-induced antinociception in both phases. Although the highest dose of SB334867 and TCS OX2 29 (30 nM) was effective in both phases, the TCS OX2 29 but not SB334867 at the dose of 10 nM could not reduce the antinociceptive responses induced by LH stimulation during the first (early) phase. It suggests that contribution of accumbal orexinergic receptors in the first phase of formalin test is more than the second (late) phase, and these results provide further evidence for the involvement of orexinergic system in the modulation of inflammatory orofacial pain.

Indexed as

Analgesics, Non-NarcoticAnimalsBenzoxazolesCarbacholFacial PainFormaldehydeHypothalamic Area, LateralIsoquinolinesMaleNaphthyridinesNociceptionNucleus AccumbensOrexin Receptor AntagonistsOrexin ReceptorsPyridinesRats, Wistar1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-((4-pyridinylmethyl)amino)-1-butanoneAnalgesics, Non-NarcoticBenzoxazolesCarbacholFormaldehydeHcrtr1 protein, ratHcrtr2 protein, ratIsoquinolinesNaphthyridinesOrexin Receptor AntagonistsOrexin ReceptorsPyridinesUreaFormalin testLateral hypothalamusNucleus accumbensOrexinOrofacial painRat

Identifiers

PMID31965554
OpenAlexW3002609266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.